Attila S.
- Country
- Hungary
- Department
- Aneszteziológiai és Intenzív Terápiás Osztály
Research Overview
- Evaluation of Recombinant Human Plasma Gelsolin in Moderate-to-Severe Acute Respiratory Distress Syndrome Due to Pneumonia or Other Infections
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAL02 ADMINISTERED INTRAVENOUSLY IN ADDITION TO STANDARD OF CARE IN SUBJECTS WITH SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP)
Data & Insights
Has run more than one trial at 10 of 89 partner sites.
Specializations
Respiratory Infections
This investigator specializes in treating severe community-acquired bacterial pneumonia (SCABP), conducting research into innovative therapeutic approaches for managing acute respiratory infections.
- Bacterial pneumonia management
- Community-acquired infections
- Standard of care optimization
Their work includes evaluation of novel therapeutic agents in combination with established treatment protocols.
Critical Respiratory Care
The investigator focuses on treating Acute Respiratory Distress Syndrome (ARDS), particularly cases arising from pneumonia and other infectious causes.
- ARDS treatment protocols
- Infection-induced respiratory failure
- Novel protein therapeutics
Their research encompasses intravenous protein-based treatments for moderate to severe respiratory conditions.
Therapeutic Innovation
The investigator studies plasma protein therapeutics and their application in severe respiratory conditions, with particular attention to patient safety and clinical recovery outcomes.
- Clinical efficacy assessment
- Safety profile evaluation
- Treatment response monitoring
Their work involves investigating new therapeutic compounds alongside standard treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.